par Vincent, Jean Louis
Référence Nature Reviews Nephrology, 5, 10, page (559-560)
Publication Publié, 2009
Article révisé par les pairs
Résumé : The recent eUphAS trial was stopped early because of reduced mortality in patients with sepsis treated with polymyxin b hemoperfusion. So should we rush to offer this technique to all patients with sepsis? not quite so fast. © 2009 Macmillan Publishers Limited. All rights reserved.